Screening for abdominal aortic aneurysms using portable ultrasound in general practice
Official title: Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound: Cluster Randomized Controlled Prospective Multicenter Study in Two Parallel Groups 1:1 in Open-label
Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT05617326 · Data updated 2026-11-12
This study tests whether using portable ultrasound in regular doctor's offices can help find abdominal aortic aneurysms earlier in men aged 65 to 75 who smoke or have smoked, and in people aged 50 to 75 with a family history of the condition.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 75 Years |
| Sex | Men only |
| Enrollment | 400 (estimated) |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild Research network |
| Locations | 6 sites (Lyon and 5 other locations) |
| Status | Recruiting |
| Started | October 2, 2023 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | October 6, 2026 |
| Trial ID | NCT05617326 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are male smokers or former smokers aged 65 to 75 years, or individuals aged 50 to 75 years with a family history of AAA.
✕Probably not a fit
Patients with a previous AAA screening within the last 5 years or those unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to implement screening for abdominal aortic aneurysms (AAA) in general practice using ultraportable ultrasound technology. It targets male smokers and former smokers aged 65 to 75 years, as well as individuals aged 50 to 75 years with a family history of AAA. The screening is designed to be rapid, noninvasive, and reproducible, addressing the low access rates to recommended AAA screenings. By conducting these screenings in general practice settings, the study seeks to improve early detection and reduce mortality associated with ruptured AAAs.
Why it matters
Potential benefit: If successful, this screening approach could significantly reduce mortality rates from abdominal aortic aneurysms through earlier detection.
How similar studies have gone: Previous studies have demonstrated the effectiveness of ultrasound screening for AAA, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male * In the absence of a family history of AAA: Patient aged 65 to 75 years, chronic current or past smoker, active smoker (defined as having smoked at least one cigarette per day) or former smoker (defined as having quit smoking less than 20 years ago, regardless of the number of cigarettes smoked). * If there is a family history of AAA: Patient between 50 and 75 years of age * Express consent to participate in the study * Affiliated or beneficiary of a social security plan Exclusion Criteria: * Patient with a legal protection measure * Patient with previous AAA screening less than 5 years old * Patient unable to understand the study / give informed consent (cognitive impairment, communication impairment)
Where it's running
-
Cabinet IPSO Brotteaux
Lyon, France Recruiting -
Cabinet IPSO Saint Martin
Paris, France Recruiting -
Cabinet IPSO Nation
Paris, France Recruiting -
Cabinet IPSO Richard-Lenoir
Paris, France Recruiting -
Cabinet IPSO Italie
Paris, France Recruiting -
Cabinet IPSO Ourcq
Paris, France Recruiting
Study contacts
- Principal investigator: Hervé Picard, MD — Hôpital Fondation A. de Rothschild
- Study coordinator: Amélie YAVCHITZ, MD
- Email: ayavchitz@for.paris
- Phone: 148036454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardiovascular Rehabilitation After Abdominal Aortic Aneurysm Repair
This study tests whether a structured cardiovascular rehabilitation program after abdominal aortic aneurysm repair leads to better fitness and quality of life than standard postoperative care.
-
Imaging inflammation in abdominal aortic aneurysm using a PET tracer
Researchers are testing whether a new PET tracer, 64Cu-DOTA-ECL1i, can image inflammation in an abdominal aortic aneurysm.
-
Poland–Italy Aortic Bridge Registry: PERCUTEK Tycheseal for Abdominal Aortic Aneurysm
This registry will see how well the PERCUTEK Tycheseal stent-graft works and how safe it is for adults having endovascular repair of abdominal aortic aneurysms.
-
PET scan to image MMP activity in abdominal aortic aneurysm
We will test whether a new PET tracer ([64Cu]-RYM2) can safely image MMP activity in people with abdominal aortic aneurysm and in healthy volunteers.
-
CTA registry for abdominal aortic aneurysm measurements
This registry will collect CT angiography scans from people with abdominal aortic aneurysms to see if CTA measurements reliably describe aneurysm size and features.
-
Cygnum aneurysm sac lining used with EVAR for abdominal aortic aneurysm
This trial will test whether adding the Cygnum sac lining to standard EVAR is safe and helps prevent type II endoleaks in people with abdominal aortic aneurysms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.